Literature DB >> 28919620

Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.

A Begum1, M A Baten, Z Begum, M M Ahsan, S F Rahman, F Chowdhury, A H Khan.   

Abstract

In spite of the global decline in its incidence and mortality, gastric carcinoma still remains a major cause of death due to cancer. Early detection of gastric carcinoma is expected to reduce mortality rates. The applications of measuring of pepsinogen I and pepsinogen II are useful in screening of gastric carcinoma. This cross sectional comparative study was done to find out the correlation of histopathological pattern of gastric carcinoma with serum pepsinogen I & II ratio in the Department of Pathology, Sylhet MAG Osmani Medical College, Sylhet, Bangladesh from January 2010 to December 2010. For these purpose 40 patients with gastric carcinoma, endoscopically visible and histopathologically proved malignant lesions were enrolled as case group. Forty subjects with normal upper GI endoscopy were taken as control. Five ml of venous blood was taken from both case and control subjects to determine serum pepsinogen I and pepsinogen II level by ELISA method, subsequently pepsinogen I and II ratio was calculated. In this study different cut off values of serum pepsinogen I and II ratio was determined and the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 70.0%, 97.5% 96.6% 76.5% and 83.8% respectively, at cut off value of 6. Which is the most suitable cut off point of serum pepsinogen I and II ratio for gastric cancer screening.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28919620

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  3 in total

1.  Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Hafeza Aftab; Ratha-Korn Vilaichone; Phawinee Subsomwong; Iswan Abbas Nusi; Ari Fahrial Syam; Thawee Ratanachu-Ek; Dalla Doohan; Gontar Siregar; Yudith Annisa Ayu Rezkitha; Kartika Afrida Fauzia; Varocha Mahachai; Yoshio Yamaoka
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

2.  The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis.

Authors:  Ling Liu; Junjie Lang; Yuelong Jin; Yan Chen; Weiwei Chang; Yingshui Yao; Jiegen Yu
Journal:  Gastroenterol Res Pract       Date:  2019-01-21       Impact factor: 2.260

3.  Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.

Authors:  Weiwei Zeng; Shuxiang Zhang; Lei Yang; Wenchao Wei; Jie Gao; Ni Guo; Fengting Wu
Journal:  BMC Med Genet       Date:  2020-02-10       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.